Irbesartan HCT Sanofi Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan hct sanofi

sanofi-aventis australia pty ltd - hydrochlorothiazide; irbesartan -

LASIX 20 MG TABLETS 20 Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

lasix 20 mg tablets 20 milligram tablets

sanofi-aventis ireland limited t/a sanofi - furosemide - tablets - 20 milligram

Lasix 20mg/2ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

lasix 20mg/2ml solution for injection or infusion

sanofi-aventis ireland limited t/a sanofi - frusemide - solution for injection/infusion - 20 mg/2ml - sulfonamides, plain; furosemide

LASIX 40 MG TABLETS 40 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

lasix 40 mg tablets 40 milligram

sanofi-aventis ireland limited t/a sanofi - furosemide - 40 milligram

Cerubidin 20 mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

cerubidin 20 mg powder for concentrate for solution for infusion

sanofi-aventis ireland limited t/a sanofi - daunorubicin hydrochloride - powder for concentrate for solution for infusion - 20 milligram(s) - anthracyclines and related substances; daunorubicin

FASTURTEC rasburicase (rys) 1.5mg powder for injection vial with diluent Australia - English - Department of Health (Therapeutic Goods Administration)

fasturtec rasburicase (rys) 1.5mg powder for injection vial with diluent

sanofi-aventis australia pty ltd - rasburicase, quantity: 1.5 mg - injection - excipient ingredients: poloxamer; water for injections - rasburicase is indicated for the treatment and prophylaxis of acute hyperuricaemia, in patients with haematological malignancy at risk of a rapid tumour lysis.

Fasturtec New Zealand - English - Medsafe (Medicines Safety Authority)

fasturtec

sanofi-aventis new zealand limited - rasburicase 7.5mg - powder for infusion - 7.5 mg - active: rasburicase 7.5mg excipient: alanine dibasic sodium phosphate dihydrate dibasic sodium phosphate dodecahydrate mannitol monobasic sodium phosphate poloxamer 188 water for injection - the treatment and prophylaxis of acute hyperuricaemia, in patients with haematological malignancy at risk of a rapid tumour lysis.